restricted stock units

Arcutis granted 309,000 equity awards to 40 new hires. Company seeks FDA approval to expand ZORYVE cream to treat atopic dermatitis in infants as young as 3 months.

Pacira BioSciences granted inducement equity awards to 10 new employees, including stock options and RSUs valued at approximately $1.5M, under Nasdaq rules.

Cue Biopharma grants inducement equity to new President and CEO Dr. Shao-Lee Lin and six employees under Nasdaq rules, signaling leadership transition and growth strategy.

SCYNEXIS grants 125,000 stock options at $0.93/share and 20,000 RSUs to new VP under Nasdaq inducement rules.

NewAmsterdam Pharma approved inducement grants totaling 50,400 options and 15,400 RSUs to five new non-executive employees under Nasdaq compliance rules.

ORIC Pharmaceuticals granted 80,000 options and 15,000 RSUs to new hire under Nasdaq Rule 5635(c)(4), reflecting ongoing biotech talent competition.

Intellia Therapeutics grants 67,150 RSUs to 13 new employees under Nasdaq inducement rules, signaling active talent acquisition in competitive gene-editing sector.

Taysha Gene Therapies grants 300,000 RSUs and options to purchase 92,400 shares to four new employees under its 2023 Inducement Plan.

NewAmsterdam Pharma grants 15,000 options and 3,200 RSUs to two new executives, complying with Nasdaq listing regulations.

Damora Therapeutics appoints Jennifer Jarrett as CEO, grants her 2M share awards. Company also awards equity to four new employees under Nasdaq inducement rules.

Bausch + Lomb director Alfonso Eduardo purchased $77,000 in stock while company matched purchase with restricted units, advancing his mandatory equity ownership requirement.

Tango Therapeutics grants new employee 367,500 stock options and 60,000 RSUs valued at $11.94 exercise price under inducement plan.

Pacira BioSciences awarded stock options and RSUs to three new employees totaling 7,900 shares at $22.10 exercise price under its inducement plan.

Penguin Solutions awards equity package including RSUs and performance-based PSUs to new Chief Product Officer, signaling strategic investment in product leadership.

BioCryst awards 65,850 RSUs to six new employees under Nasdaq inducement rule, vesting over four years starting March 2027.

Genmab corrects insider transaction report, fixing share price from DKK 0.00 to DKK 1,867.50 for executive RSU settlement.

Genmab A/S disclosed RSU vesting for top executives as part of deferred bonus arrangements, triggering mandatory insider trading disclosures under EU regulations.

Rent the Runway grants Executive Chair Fonseca 802K RSUs as an inducement award, vesting over three years to retain key talent.

Artiva Biotherapeutics appoints veteran pharma executive Thad Huston as CFO with 30+ years experience, ahead of key FDA feedback and clinical data milestones.

Cirrus Logic EVP sells $429K in stock amid strong earnings. Multiple executives engage in routine transactions, with the company's shares up 18% year-to-date.